Background:
The Council has reached political agreement on two
legislative proposals in the so-called "pharma review package":
concerning a proposal for a regulation on the authorisation and
supervision of medicinal products, as well as a proposal for a
directive on the Community code for medicinal products for human
use. This new legislative package juggles to provide incentive for
the pharmaceutical industry to innovate and to preserve at the same
time the right of patients to access cheaper products.